It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company’s lead candidate TP-03, is a novel drug that ...
He will also invest in a queen bee artificial insemination kit. This will enable him to selectively breed queen bees that are better suited to the region's cooler climate and more resistant to Varroa ...